BriaCell Therapeutics logo

BriaCell Therapeutics

BCTX | NASDAQ
Chart Builder DCF Calculator
$3.30
-$0.09 (-2.65%)
At close: Nov 16, 2026, 4:00 PM ET
$3.30
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.65%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
21.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #980/1021 (Top 96%)

Key Statistics

Market Data

Market Cap $28.82M
1D Range
3.29 3.44
52W Range
2.74 12.64

Valuation (TTM)

PE -0.35
PB 1.76
EV/EBITDA -0.23

Valuation (NTM)

Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Loading financial charts...

Profile

BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is ...

Sector Healthcare
Industry Biotechnology
Employees 16
IPO Date Mar 14, 2012
Fiscal Year August - July

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.